Qualify For a Burial Plan With Hepatitis C
Quick Tip: Complete the Instant Quotes form to receive an instant listing of carrier quotes - free - with no obligation. You can begin your free online research - right now...
Benefit Information For Virginia Citizens Only
You may qualify for a state-regulated program to pay for your final expenses. It is important you know how to qualify for this life insurance benefit available to you. This benefit will pay for 100% of all funeral expenses up to $35,000. This payment is tax free for Virginia residents. You are entitled to receive no-cost information as a resident of Virginia. IMPORTANT – Return this postage paid card within 5 days.
If you are currently undergoing treatment for hepatitis C you may qualify for a life insurance policy with the following guarantees:
These programs have the following guarantees
1. First Day Coverage. You are fully protected the very first day your coverage goes into effect with no exclusions and no waiting period.
2. Ease of issue. No physical exams.
3. Your premiums will never go up. Lock into a rate at your current age and the cost will never increase regardless of changes to your health and age.
4. You benefits will never go down. Regardless of changes to your health and age.
5. All programs build cash values.
6. The benefit is paid to your beneficiary tax free on the worst week of their life.
7. Your policy can never be cancelled as long as premium payments are made.
8. This is a protected asset that you will never be forced to liquidate.
Hepatitis C
Description
A liver disease that persists over a long period of time, potentially resulting in a progressive destruction of the liver. In the end stages patients may have problems clotting their blood, and can become confused. There are many causes with longstanding alcohol abuse and viral infections being the most common.
Symptoms
Abdominal pain, abdominal bloating, easy bleeding, vomiting, confusion, yellowing skin, weakness.
Treatment
Treatment depends on the cause of the liver failure and the extent of the liver failure but may include: diuretics for fluid overload, lactulose for confusion, blood products or vitamin K for bleeding, and/or antibiotics for infection. A surgical procedure, called transjugular intrahepatic portosystemic shunt (TIPS) or liver transplant may be recommended.
Until recently, there was no cure for chronic hepatitis C. But new antiviral drugs, such as simeprevir (Olysio, sofosbuvir (Sovaldi), sofosbuvir-ledipasvir combination (Harvoni), suggest cure for some may be possible. In some instances, the infection causes liver failure and those individuals may be considered for a liver transplant. Hepatitis A and B vaccines will most likely be recommended to prevent further damage to the liver.
Peginterferon Alfa-2A
Peginterferon Alfa-2A is used alone or in combination with ribavarin (a medication) to treat chronic (long term) hepatitis C infection (selling of the liver caused by a virus) in people who show signs of liver damage and who have not been treated with interferon alpha (medication similar to peg-interferon alfa-2a) in the past. Peginterferon alfa-2a is also used to treat chronic hepatitis B infection (swelling of the liver casued by a virus) in people who show signs of liver damage. Peginterferon alfa-2A is in a class of medications called interferons. Peginterferon is a combination of interferon and polyethylene glycol, which helps the interferon stay active in your body for a longer period of time. Peginerferon works by decreasing the amount of hepatitis C virus (HCV) or hepatitis B virus (HBV) in the body. Peginterferon alfa-2A may not cure hepatitis C or hepatitis B or prevent you from developing complications of hepatitis C or hepatitis B such as cirrhosis (scarring) of the liver, liver failure, or liver cancer. Peginterferon alfa-2A may not prevent the spread of hepatitis C or hepatitis B to other people.
Peginterferon Alfa-2B
Peginterferon Alfa-2B is used alone or in combination with ribavarin (a medication) to treat chronic (long term) hepatitis C infection (selling of the liver caused by a virus) in people who show signs of liver damage and who have not been treated with interferon alpha (medication similar to peg-interferon alfa-2B) in the past. Peginterferon alfa-2a is also used to treat chronic hepatitis B infection (swelling of the liver casued by a virus) in people who show signs of liver damage. Peginterferon alfa-2B is in a class of medications called interferons. Peginterferon is a combination of interferon and polyethylene glycol, which helps the interferon stay active in your body for a longer period of time. Peginerferon works by decreasing the amount of hepatitis C virus (HCV) or hepatitis B virus (HBV) in the body. Peginterferon alfa-2B may not cure hepatitis C or hepatitis B or prevent you from developing complications of hepatitis C or hepatitis B such as cirrhosis (scarring) of the liver, liver failure, or liver cancer. Peginterferon alfa-2B may not prevent the spread of hepatitis C or hepatitis B to other people.
Ribavirin
Ribavirin is used with an interferon medication such as peginterferon alfa-2A (Pegasys) or peginterferon alpha-2B (PEG-Intron) to treat hepatitis C in people who have not been treated with an interferon before. Ribavirin is in a class of antiviral medications called nucleoside analogues. It works by stopping the virus that causes hepatitis C from spreading inside the body. It is not known if treatment that includes ribavirin and another medication cures hepatitis C infection, prevents live damage that may be caused by hepatitis C, or prevents the spread of hepatitis C to other people.
If you are being treated for hepatitis C and you have been declined for a life insurance policy or a burial plan you should contact us at LifePolicyShopper.com. We work with a carrier that offers first day coverage to those being treated for hepatitis C. If you are on a guaranteed issue plan we can most certainly save you money on a monthly basis and get you first day coverage.
So glad you're here - check out - Final Expense Life Insurance With Hepatitis C.
Last Updated on October 13, 2017 by lifepolicyshopper